Trial intelligence / Profile preview

Gensci094 vs Gonal-F in ART-controlled ovarian stimulation

CTR20212525Phase 2Completed

Sponsor
Chengdu Jinkai Biotechnology
Start
Oct 2021
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 2 trial of corifollitropin alfa in superovulation, sponsored by Chengdu Jinkai Biotechnology. Started Oct 2021; status: completed.

02

Drugs

corifollitropin alfa
03

Conditions

superovulation

Beyond the preview

Go deeper on CTR20212525.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20212525.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call